type here...

CATEGORIES

Patient Zone

LATEST

1...345...60Page 4 of 60

TRENDING

EDITORS CHOICE

First Drug Synthesized by AI Goes into Clinical Trials

Dr Sohail Merchant -
If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

The Hidden “Friction Tax”

Gil Bashe, Medika Life Editor -
Health innovation loves the language of efficiency: faster, smarter, automated, digital, self-service and AI-enabled. Those words open doors to opportunity because they promise to...

Monoclonal Antibody Infusions. The Plan B Emergency Contraception for Covid?

Medika Life -
Monoclonal antibody infusions for Covid-19 suffer from one major flaw and it doesn't revolve around efficacy, but the speed of treatment

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories